We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




3D Network Structures Improve Survival of Transplanted Stem Cell-Derived Neurons

By LabMedica International staff writers
Posted on 27 Mar 2016
Neurological disease researchers have developed a method for treating neurodegenerative diseases such as Parkinson's by transplanting three-dimensional (3D) networks of stem cell-derived neurons into the damaged brain tissue.

Cell replacement therapy using human pluripotent stem cell-derived neurons has the potential to correct neurodegenerative damage and central nervous system injuries, but transplantation of dissociated and spatially disorganized neurons portends poor cell survival and incomplete functional development.

Investigators at Rutgers University (Piscataway, NJ, USA) and Stanford University (Palo Alto, CA, USA) recently described the design of three-dimensional scaffolds based on tunable electrospun microfibrous polymeric substrates. More...
These scaffolds promoted in situ stem cell neuronal reprogramming, neural network establishment, and supported neuronal engraftment into the brain.

The investigators reported in the March 17, 2016, online edition of the journal Nature Communications that they had successfully grafted scaffold-supported, reprogrammed neuronal networks into organotypic hippocampal brain slices. This approach yielded an approximately 3.5-fold improvement in neurite outgrowth and increased action potential firing relative to injected isolated cells. Transplantation of scaffold-supported neuronal networks into mouse brain striatum improved survival by about 38-fold at the injection site relative to injected isolated cells, and allowed delivery of multiple neuronal subtypes.

"If you can transplant cells in a way that mimics how these cells are already configured in the brain, then you are one step closer to getting the brain to communicate with the cells that you are now transplanting," said senior author Dr. Prabhas V. Moghe, professor of biomedical, chemical, and biochemical engineering at Rutgers University. "In this work, we have done that by providing cues for neurons to rapidly network in three dimensions."

Related Links:

Rutgers University
Stanford University



New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Clinical Informatics Platform
CLARION™
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.